Antonella Capozzi

Antonella Capozzi

Auto-generated profile, based on publicly available information

Antonella Capozzi

Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
EPElisabetta Profumo
Elisabetta Profumo
Brigitta ButtariBrigitta Buttari
Brigitta Buttari
LTLavinia Tinaburri
Lavinia Tinaburri
DDDaniela D'Arcangelo
Daniela D'Arcangelo
Maurizio SoriceMaurizio Sorice
Maurizio Sorice
RRRachele Riganò
Rachele Riganò
We have previously demonstrated that human heat shock protein 90 (HSP90), an intracellular self protein, is the target of cellular and humoral autoimmune responses in patients with carotid atherosclerosis. In this study, we evaluated in vitro whether oxidative stress, a feature of atherosclerotic plaque, alters HSP90 expression in endothelial cells, thus inducing surface localization of this molecule and whether the antioxidant compound 7,8‐dihydroxy‐4‐methylcoumarin (7,8‐DHMC) is able to prevent oxidative stress‐induced alterations of HSP90 localization. By the use of flow cytometry, immunofluorescence, enzyme‐linked immunosorbent assay, and semiquantitative reverse‐transcription polymerase chain reaction, we demonstrated that exposure of human umbilical vein endothelial cells (HUVEC) to the prooxidant compound H2O2 upregulated HSP90 surface expression and reduced its secretion without altering HSP90 gene expression and intracytoplasmic protein levels. Pretreatment of HUVEC with 7,8‐DHMC prevented H2O2‐induced alterations of HSP90 cellular distribution and secretion. Our results suggest that the strong oxidative conditions of atherosclerotic plaques promote the upregulation of HSP90 surface expression on endothelial cells, thus rendering the protein a possible target of autoimmune reactions. The antioxidant 7,8‐DHMC, by preventing oxidative‐stress‐triggered HSP90 surface upregulation, may be useful to counteract possible autoreactive reactions to HSP90.

19 December 2017 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
VMValeria Manganelli
Valeria Manganelli
ACAntonella Capozzi
Antonella Capozzi
STSimona Truglia
Simona Truglia
CAcristiano alessandri
cristiano alessandri
ELEmanuela Lococo
Emanuela Lococo
Roberta MisasiRoberta Misasi
Roberta Misasi
Pregnancy problems are common in patients with rheumatic disease; indeed, autoimmune disorders and autoantibodies can affect pregnancy progress and lead to maternal complications. Recent studies have highlighted a close association between HMGB1, chronic inflammation, and autoimmune diseases. Thus, in this investigation, we analyzed serum levels of HMGB1, an alarmin which plays a pivotal role in inducing and enhancing immune cell function. Sera from 30 patients with antiphospholipid syndrome (11 primary and 19 secondary APS), 35 subjects with pregnancy morbidity, and 30 healthy women were analysed for HMGB1 and its putative receptor RAGE (sRAGE) by Western blot and for TNF-α by ELISA. Results revealed that APS patients showed significantly increased serum levels of HMGB1, sRAGE, and the proinflammatory cytokine TNF-α, as compared to healthy women. However, also, the pregnancy morbidity subjects showed significantly increased levels of HMGB1 and sRAGE as well as TNF-α compared to healthy women. Our findings suggest that in subjects with pregnancy morbidity, including obstetric APS, elevated levels of HMGB1/sRAGE may represent an alarm signal, indicating an increase of proinflammatory triggers. Further studies are needed to evaluate the role of HMGB1/sRAGE as a possible tool to evaluate the risk stratification of adverse pregnancy outcomes.

26 December 2021 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
ACAntonella Capozzi
Antonella Capozzi
GRGloria Riitano
Gloria Riitano
SRSerena Recalchi
Serena Recalchi
VMValeria Manganelli
Valeria Manganelli
FPFabio M Pulcinelli
Fabio M Pulcinelli
Maurizio SoriceMaurizio Sorice
Maurizio Sorice

25 September 2024 in Reumatismo
Verified
Journal Article
Open access
PDF file
SMS. Mancuso
S. Mancuso
MMManuela De Michele
Manuela De Michele
STSimona Truglia
Simona Truglia
ACA. Capozzi
A. Capozzi
LRL. Rapino
L. Rapino
FCF. Conti
F. Conti
Cerebrovascular events (CE) are one of the most common and severe events in antiphospholipid syndrome (APS), a condition characterized by thrombosis and circulating anti-phospholipid antibodies (aPL). Seronegative APS (SN-APS) refers to a group of patients with clinical features of APS but persistently negative tests for “criteria aPL”: anti-cardiolipin antibodies (aCL) and anti-β2glycoprotein I antibodies detected by enzyme-linked immunosorbent assay (ELISA), and the lupus anticoagulant detected by clotting assays. We report a series of five cases of SN-APS in young or middle-aged patients who tested positive for “non-criteria” aPL. We retrospectively collected cases of SN-APS patients who experienced CE without an identified cause despite an extensive diagnostic work-up and tested negative for criteria aPL. All the patient sera were tested for aCL by immunostaining on thin-layer chromatography (TLC) and anti-vimentin/cardiolipin (aCL/Vim) by ELISA. We identified five cases of female patients aged 21 to 58 years, evaluated at the Rheumatology Unit and/ or Stroke Unit/Emergency Department of the Sapienza University Hospital of Rome, “Policlinico Umberto I”. All patients presented a clinical history suggestive of APS. All the patients tested positive for aCL by TLC-immunostaining, and one patient was positive for aCL/Vim. In young or middle-aged patients with cryptogenic CE and a clinical history suggestive of APS, the use of new diagnostic tools for identifying aPL, if validated in future studies, could represent an important step in the prompt diagnosis of APS.

5 September 2026 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
OUOzge Ulker
Ozge Ulker
ACAntonella Capozzi
Antonella Capozzi
NSNisa Nur Sari-Goktas
Nisa Nur Sari-Goktas
Maurizio SoriceMaurizio Sorice
Maurizio Sorice
Luciano SasoLuciano Saso
Luciano Saso
Brigitta ButtariBrigitta Buttari
Brigitta Buttari

13 July 2026 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Open access
DCDaniela Caissutti
Daniela Caissutti
CNCandelise Niccolò
Candelise Niccolò
CMCamilla Moliterni
Camilla Moliterni
ACAntonella Capozzi
Antonella Capozzi
ALAgostina Longo
Agostina Longo
TGTina Garofalo
Tina Garofalo
Neuroglobin (Ngb) is a nerve hemeprotein that acts as a neuroprotectant against multiple brain injuries, including oxidative stress and β-amyloid toxicity. Besides inhibiting apoptosis and scavenging ROS/RNS, Ngb overexpression promotes autophagy, a highly conserved catabolic process essential for maintaining cellular homeostasis under both basal and stress conditions. Although Ngb upregulation has proven effective in animal models of neurological diseases, its effects have not yet been studied in three-dimensional (3D) cell cultures, which better mimic in vivo tissue architecture than monolayers. Therefore, in the present work we developed a simple yet reliable 3D model of Ngb overexpression using human SH-SY5Y neuroblastoma cells and examined its response to 1-methyl-4-phenylpyridinium (MPP+), a well-established in vitro model of Parkinson's disease (PD)-related neurodegeneration. Control and Ngb-overexpressing spheroids were generated using the hanging drop method. Ngb overexpression decreased MPP+ -induced ROS production and cell death, thus validating our 3D model. Additionally, biochemical fractionation and Thioflavin-S staining showed that Ngb upregulation reduces MPP+ -induced impairment of autophagy and amyloid accumulation, key pathological features of neurodegeneration. Overall, our findings emphasize the importance of 3D cultures for studying Ngb-mediated neuroprotection and suggest that Ngb upregulation may prevent the disruption of neuronal proteostasis under neurotoxic stress.